Results 101 to 110 of about 471,172 (312)

Existing Data Sources for Clinical Epidemiology: Database of the National Hospital Organization in Japan

Clinical Epidemiology, 2022
Natsuko Kanazawa,1,* Takuaki Tani,1,* Shinobu Imai,1– 3 Hiromasa Horiguchi,1 Kiyohide Fushimi,1,2 Norihiko Inoue1,2 1Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Tokyo,
Kanazawa N, Tani T, Imai S, Horiguchi H, Fushimi K, Inoue N   +5 more
doaj  

Comprehensive Medication Management: Implications for the Patient and Pharmacist [PDF]

, 2017
Since 1979, state pharmacy practice laws have begun to allow pharmacists to provide advanced levels of care in collaboration with prescribers. These might be termed medication therapy management, collaborative practice, comprehensive medication ...
Brayer, Hayden, Bunting, Barry, DeLucenay, Alexander, Williams, Karl   +3 more
core   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

OPTimising MEDicine information handover after Discharge (OPTMED-D): protocol for development of a multifaceted intervention and stepped wedge cluster randomised controlled trial

Trials
Background General practitioners (GP) and community pharmacists need information about hospital discharge patients’ medicines to continue their management in the community.
Laetitia Hattingh, Melissa T. Baysari, Holly Foot, Tin Fei Sim, Gerben Keijzers, Mark Morgan, Ian Scott, Richard Norman, Faith Yong, Barbara Mullan, Claire Jackson, Leslie E. Oldfield, Elizabeth Manias   +12 more
doaj   +1 more source

Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study. [PDF]

, 2019
BackgroundMedication non-adherence is a major contributor to poor outcomes in diabetes. Previous research has shown an association between use of mail order pharmacy delivery and better medication adherence, but little is known about the barriers and ...
Brown, Susan D, Chau, Christopher V, Duru, O Kenrik, Karter, Andrew J, Marshall, Cassondra J, Schmittdiel, Julie A, Trinacty, Connie M, Wharam, J Frank, Wiley, Deanne   +8 more
core  

Predicting Loss of Ambulation in Limb Girdle Muscular Dystrophy R9

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Limb girdle muscular dystrophy type R9 (LGMDR9) results from biallelic variants in FKRP. There is limited data to predict loss of ambulation (LOA) among those with LGMDR9. Methods Participants in an ongoing dystroglycanopathy natural history study (NCT00313677) with FKRP variants who had achieved ambulation and were more than 3 ...
Chandra L. Miller, Lauren N. Coffey, Shelley R. H. Mockler, Katie M. Laubscher, Carrie M. Stephan, M. Bridget Zimmerman, Katherine D. Mathews   +6 more
wiley   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Characterization of Clinical Phenotype to Glial Fibrillary Acidic Protein Concentrations in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the concentration of glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and plasma in Alexander disease (AxD) and whether GFAP levels are predictive of disease phenotypes. Methods CSF and plasma were collected (longitudinally when available) from AxD participants and non‐AxD controls.
Amy T. Waldman, Asako Takanohashi, Joshua Y. Joung, Geraldine W. Liu, Kaley Arnold, Amy Pizzino, Walter Faig, Sarah Woidill, Sona Narula, Adeline L. Vanderver   +9 more
wiley   +1 more source

Managing minor ailments and pharmacy services: How do people make their decisions?

PLoS ONE
BackgroundHealthcare systems face challenges such as rising costs and workforce shortages. Optimal resource allocation is needed, notably in the management of minor ailments.
Léa Charnaux, Jérôme Berger, Clémence Perraudin   +2 more
doaj   +1 more source

The Risk of Severe Fibromyalgia, Depression, Anxiety, and Insomnia Symptoms in Arab Women: An Implication of Self-Medication with Analgesics? A Cross-Sectional Study

Medicina
Background and Objectives: The investigation of the psychosomatic symptoms in women residing in developing countries is still emerging. To be precise, the prevalence and correlates of severe fibromyalgia, depression, anxiety, and insomnia are ...
Omar Gammoh, Mariam Al-Ameri, Ghaith Altaani, Ahmed Al-smadi, Reham Al-Zegoul, Talal Massad, Ahmad F. Klaib, Mervat Alsous, Ammena Y. Binsaleh, Sireen Abdul Rahim Shilbayeh   +9 more
doaj   +1 more source